Passage BIO, Inc. (PASG): Capital Expenditures

Annual figures by period end, from SEC filings.

$34.0K

Year ended 2024-12-31

Period ended	Capital Expenditures	Change YoY	Source filing
2024-12-31	$34.0K	n/a	2026-03-03, From 2024-01-01